Sergio
Vaño Galván
Profesor/a Asociado/a en CC. de la Salud

Andy
Goren
Publications by the researcher in collaboration with Andy Goren (22)
2024
-
Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia
Journal of Cosmetic Dermatology, Vol. 23, Núm. 11, pp. 3767-3773
2022
-
SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth
Journal of Cosmetic Dermatology, Vol. 21, Núm. 1, pp. 343-346
2021
-
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia
Journal of the European Academy of Dermatology and Venereology
-
Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients
Journal of the European Academy of Dermatology and Venereology
-
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
Medical Hypotheses, Vol. 146
-
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
Journal of the European Academy of Dermatology and Venereology
-
Clinical symptoms of hyperandrogenic women diagnosed with COVID-19
Journal of the European Academy of Dermatology and Venereology
-
Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
Frontiers in Medicine, Vol. 8
-
Reply to comment on: The Gabrin sign
Journal of the American Academy of Dermatology
-
Time of onset and duration of post-COVID-19 acute telogen effluvium
Journal of the American Academy of Dermatology, Vol. 85, Núm. 4, pp. 975-976
2020
-
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain – A potential clue to the role of androgens in COVID-19 severity
Journal of Cosmetic Dermatology
-
Androgen sensitivity gateway to COVID-19 disease severity
Drug Development Research
-
Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
Journal of the American Academy of Dermatology
-
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
Journal of the American Academy of Dermatology, Vol. 83, Núm. 2, pp. 680-682
-
Clock genes may drive seasonal variation in sars-cov-2 infectivity: Are we due for a second wave of covid-19 in the fall?
Journal of Biological Regulators and Homeostatic Agents
-
Erosive pustular dermatosis of the scalp: a multicentre study
Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 6, pp. 1348-1354
-
Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response
Journal of the European Academy of Dermatology and Venereology
-
Novel “After Minoxidil” spray improves topical minoxidil compliance and hair style manageability
Journal of Cosmetic Dermatology, Vol. 19, Núm. 10, pp. 2647-2649
-
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?
Journal of Cosmetic Dermatology
-
What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy
Dermatologic Therapy